You have 9 free searches left this month | for more free features.

vortioxetine

Showing 26 - 50 of 110

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Binge Eating Disorder Trial in Chicago (Vortioxetine, Placebo)

Completed
  • Binge Eating Disorder
  • Vortioxetine
  • Placebo
  • Chicago, Illinois
    University of Chicago
Nov 19, 2020

MDD, Anxiety Disorders Trial in Worldwide (Vortioxetine)

Completed
  • MDD
  • Anxiety Disorders
  • Vortioxetine
  • Tallinn, Estonia
  • +20 more
Apr 19, 2021

Depressive Disorder, Major Trial in Worldwide (Vortioxetine)

Terminated
  • Depressive Disorder, Major
  • Vortioxetine
  • Tucson, Arizona
  • +77 more
May 17, 2022

Depressive Disorder, Major Trial in Worldwide (Vortioxetine)

Completed
  • Depressive Disorder, Major
  • Vortioxetine
  • Targovishte, Bulgaria
  • +30 more
Jun 22, 2021

Depressive Disorder, Major, Alcoholism Trial in Seoul (Vortioxetine, Acamprosate)

Unknown status
  • Depressive Disorder, Major
  • Alcoholism
  • Seoul, Korea, Republic of
    Hanyang USH
Jul 30, 2020

Depressive Disorder, Major Trial in Worldwide (Vortioxetine 10 mg/day, Vortioxetine 20 mg/day, Fluoxetine 20mg/day)

Completed
  • Depressive Disorder, Major
  • Vortioxetine 10 mg/day
  • +3 more
  • Little Rock, Arkansas
  • +97 more
Aug 29, 2022

MDD Trial in Worldwide (Vortioxetine, Desvenlafaxine)

Completed
  • Major Depressive Disorder
  • Banfield, Buenos Aires, Argentina
  • +79 more
Feb 11, 2022

Age-related Cognitive Decline Trial in Saint Louis (Vortioxetine 10 mg, Cognitive training program)

Completed
  • Age-related Cognitive Decline
  • Vortioxetine 10 mg
  • Cognitive training program
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 27, 2019

Vortioxetine for Cancer Depression: An Observational Study

Unknown status
  • Major Depressive Disorder
  • Cancer
  • Vortioxetine
  • Ipoh, Perak, Malaysia
  • +7 more
Jan 30, 2020

MDD Trial in Japan (Placebo, Vortioxetine)

Completed
  • Major Depressive Disorder
  • Placebo
  • Vortioxetine
  • Nagoya, Aichi, Japan
  • +46 more
Mar 3, 2021

Relapse, Cognitive Impairment, Depression Trial (Vortioxetine)

Unknown status
  • Relapse
  • +2 more
  • Vortioxetine
  • (no location specified)
Nov 26, 2019

Depressive Disorder, Major Depression, Depression Trial in Boston (Vortioxetine)

Terminated
  • Depressive Disorder
  • +3 more
  • Vortioxetine
  • Boston, Massachusetts
    the Massachusetts General Hospital
Sep 23, 2019

MDD Trial in Worldwide (Vortioxetine)

Completed
  • Major Depressive Disorder
  • Vortioxetine
  • Angoulême, France
  • +22 more
Mar 23, 2020

MDD Trial in United States (Vortioxetine, Placebo)

Completed
  • Major Depressive Disorder
  • Vortioxetine
  • Placebo
  • Phoenix, Arizona
  • +78 more
Dec 16, 2020

Healthy Trial in Nottingham (Vortioxetine IV, Vortioxetine SLA, Vortioxetine SLB)

Completed
  • Healthy
  • Vortioxetine IV
  • +3 more
  • Nottingham, United Kingdom
    Quotient Sciences Ltd
Jul 30, 2019

Depressive Disorder, Major Trial in Worldwide (Vortioxetine 10 mg/day, Vortioxetine 20 mg/day, Fluoxetine 20 mg/day)

Completed
  • Depressive Disorder, Major
  • Vortioxetine 10 mg/day
  • +3 more
  • Dothan, Alabama
  • +123 more
Aug 4, 2020

MDD Trial in Bulgaria, Estonia, Latvia (Vortioxetine infusion 25 mg, Vortioxetine tablets 10 mg/day, Placebo infusion)

Completed
  • Major Depressive Disorder
  • Vortioxetine infusion 25 mg
  • +3 more
  • Burgas, Bulgaria
  • +12 more
Aug 28, 2019

Hoarding Disorder Trial in Hamilton (Vortioxetine Tablets)

Unknown status
  • Hoarding Disorder
  • Vortioxetine Tablets
  • Hamilton, Ontario, Canada
    St Joseph Healthcare
Jul 26, 2019

Depression, Type 2 Diabetes Trial (Vortioxetine, Sertraline)

Completed
  • Depression
  • Type 2 Diabetes Mellitus
  • (no location specified)
Jun 11, 2019

Patient Engagement Trends in Anxiety Disorder Clinical Research

Not yet recruiting
  • Anxiety Disorder
    • San Francisco, California
      Power Life Sciences
    Nov 24, 2023

    Healthy Adult Participants Trial in Kumamoto (Vortioxetine)

    Completed
    • Healthy Adult Participants
    • Vortioxetine
    • Kumamoto, Japan
      Nishi Kumamoto Hospital
    Jun 26, 2019

    Depressive Disorder, Major Trial (Rapastinel, Vortioxetine, Placebo)

    Withdrawn
    • Depressive Disorder, Major
    • (no location specified)
    Jul 17, 2019

    MDD Trial in United States (Vortioxetine)

    Completed
    • Major Depressive Disorder
    • Vortioxetine
    • Costa Mesa, California
    • +24 more
    Jun 14, 2019

    Prediction of Adolescents With MDD Response to ECT Via MRI

    Recruiting
    • Major Depressive Disorder
    • +2 more
    • Modified Electroconvulsive Therapy
    • Conventional pharmacotherapy
    • Chongqing, Province, China
      The First Affiliated Hospital of Chongqing Medical University
    May 26, 2023

    The Antidepressant Advisor: fMRI Study to Predict Treatment

    Completed
    • Major Depressive Disorder
      • London, United Kingdom
        King's College London, IoPPN
      Jan 4, 2023